Lawrence M. Alleva
Independent Non-Executive ChairmanMr. Lawrence M. Alleva, also known as Larry, has been an Independent Non-Executive Director of Adaptimmune Therapeutics plc since March 05, 2015 and serves as its Chairman since November 14, 2025. Mr. Alleva served in a variety of office and regional practice leadership roles at PricewaterhouseCoopers LLP, most recently served as ethics and compliance leader (assurance) from 2006 until his retirement in June 2010. At PwC, he served clients ranging from Fortune 500 and multi-national companies to rapid-growth companies’ initial public offerings. Mr. Alleva also served in a senior national leadership role for PwC’s Ethics and Compliance Group to manage the design and implementation of best practice procedures, internal controls and monitoring activities, including in connection with PwC’s response to inspection reports issued by the Public Company Accounting Oversight Board (PCAOB). He was the first U.S. Ethics & Compliance Leader (Assurance) in PwC's National Office from 2006 to 2010. He is Director at Bright Horizons Family Solutions LLC. He began his career in the Syracuse office of Price Waterhouse. Admitted to the partnership in 1982, he has earned a series of successive promotions. Mr. Alleva has been a Vice Chairman of Ithaca College for a decade. He had been an Independent Director of Mersana Therapeutics, Inc. since September 5, 2017 until January 05, 2026. Mr. Alleva served clients primarily in the technology sector, as well as pharmaceutical and biotechnology companies. He served as a Director of Synlogic, Inc. until August 28, 2017. He served as a Southeast Regional Managing Partner for PricewaterhouseCoopers LLP from 1971 to June 2010, included as a partner. He had been Independent Director at Galera Therapeutics, Inc. since June 2019. He has been an Independent Director of Bright Horizons Family Solutions, Inc. (formerly, Bright Horizons Family Solutions, LLC) since September 2012. He served as a Director of Tesaro, Inc. since March 2012 until January 22, 2019. He served as an Outside Director of Mirna Therapeutics, Inc. since September 15, 2014 until August 2017. Mr. Alleva served as a Director of GlobalLogic Inc from June 2011 to June 2014. He has been a Trustee of Ithaca College. He is a member of the American Institute of Certified Public Accountants (inactive) and the advisory board of Capital Growth Atlantic and has written several articles on venture capital and financing issues. Mr. Alleva graduated from Ithaca College magna cum lade with a B.S. in Accounting. He attended Columbia University's Executive MBA (non-degree) Program.
Positions
- Company NameAdaptimmune Therapeutics plcStock CodeADAPYPositionIndependent Non-Executive ChairmanColleagues
- CJChristopher James HillCEO, CFO, Secretary & Director
- LMLawrence M. AllevaIndependent Non-Executive Chairman
- HKHelen Katrina Tayton-MartinCo-Founder
- JPJuli P. MillerVP of Corporate Affairs & Investor Relations
- DLDana LynchSenior Director of Corporate Communications
- KFKimberly FreemanVice President of Commercial Planning
- MKMalcolm K. BrennerMember of the Scientific Advisory Board
- SAStephan A. GruppMember of the Scientific Advisory Board
- TGThomas GajewskiMember of the Scientific Advisory Board
- Company NameBright Horizons Family Solutions Inc.Stock CodeBFAMPositionIndependent DirectorColleagues
- SHStephen Howard KramerCEO, President & Director
- DHDavid H. LissyNon Executive Independent Chairman
- EJElizabeth J. BolandChief Financial Officer
- MLMary Lou Burke-AfonsoChief Operating Officer of North America Center Operations
- MLMandy Lee BermanChief Operating Officer of Back-up Care & Education Advisory Services
- RMRosamund MarshallManaging Director of International
- JHJordan HitchIndependent Director
- LJLaurel J. RichieIndependent Director
